SCHEMBL23867515

SCHEMBL23867515

O=C(Cc1cccs1)Nc1ccc(Nc2nc(N3CCN(CCO)CC3)ncc2F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 6/20 0.47
▸ HTR2A P28223 5/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HTR2C P28335 2/20 0.47
▸ SRC P12931 3/20 0.46
▸ EGFR P00533 1/20 0.46
▸ SHMT2 P34897 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ CTDSP1 Q9GZU7 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ BLM P54132 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ DRD3 P35462 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867516 0.89 POLB (0.53) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867525 0.85 HTR2A (0.49) POLBHTR2ASMN1; SMN2NPC1RAB9A
SCHEMBL23867514 0.84 POLB (0.50) POLBHTR2ASMN1; SMN2NPC1RAB9A
SCHEMBL23867474 0.83 SRC (0.51) POLBHTR2ASMN1; SMN2NPC1RAB9A
SCHEMBL23867479 0.79 POLB (0.49) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867519 0.76 HTR2A (0.51) HTR2AHTR2CSRCEGFRALDH1A1
SCHEMBL30234578 0.74 POLB (0.52) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867477 0.74 POLB (0.52) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867475 0.72 POLB (0.55) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL23867574 0.71 PYGM (0.53) HTR2AHTR2CSRCDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback